Location History:
- Del Mar, CA (US) (2002 - 2012)
- La Jolla, CA (US) (2023)
Company Filing History:
Years Active: 2002-2023
Title: Innovations by Sylvia Evans
Introduction
Sylvia Evans is a prominent inventor based in Del Mar, California. She has made significant contributions to the field of medical research, particularly in the treatment of lysosomal disorders and cardiac progenitor cell development. With a total of six patents to her name, Evans continues to push the boundaries of innovation in her field.
Latest Patents
One of her latest patents focuses on methods of treating lysosomal disorders. This invention provides methods for treating a lysosomal transmembrane protein disease or disorder through the ex vivo introduction of a nucleic acid molecule into hematopoietic stem and progenitor cells (HSPCs), followed by transplantation of the HSPCs into a subject in need of treatment. Additionally, the patent includes vectors containing the nucleic acid molecule. Another significant patent relates to methods of identifying small molecules for the renewal, survival, and migration of cardiac progenitors. This invention describes a small molecule high-throughput screening assay consisting of detectably labeled cardiac progenitor cells. It also outlines a method of identifying small molecules from the high-throughput assay that affect cardiogenesis and/or modulate cardiac progenitor cell development. Furthermore, the patent describes methods of stimulating the maturation of cardiac progenitor cells using a GSK-3β inhibitor.
Career Highlights
Evans is affiliated with the University of California, where she conducts her research and develops her innovative solutions. Her work has garnered attention for its potential impact on treating serious medical conditions.
Collaborations
Some of her notable coworkers include Ju Chen and Chenleng Cai, who collaborate with her on various research projects.
Conclusion
Sylvia Evans is a trailblazer in the field of medical innovation, with her patents reflecting her commitment to advancing treatment options for complex diseases. Her contributions continue to inspire future research and development in the medical community.